Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tetanus × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1625 Glioblastoma 1522 Glioma 960 Central Nervous System Neoplasms 519 Astrocytoma 509 Neuroblastoma 475 Gliosarcoma 408 Oligodendroglioma 317 Neoplasms 269 Breast Neoplasms 242 Medulloblastoma 225 Carcinoma, Non-Small-Cell Lung 189 Recurrence 169 Sarcoma 161 Melanoma 159 Ependymoma 157 Meningioma 155 Neoplasm Metastasis 153 Lung Neoplasms 128 Lymphoma 114 Osteosarcoma 111 Neurofibromatosis 1 104 Meningeal Carcinomatosis 100 Wilms Tumor 98 Ovarian Neoplasms 93 Diffuse Intrinsic Pontine Glioma 91 Rhabdomyosarcoma 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Lymphoma, Non-Hodgkin 89 Burkitt Lymphoma 79

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡